18VAC110-20 Regulations Governing the Practice of Pharmacy  

  • REGULATIONS
    Vol. 32 Iss. 5 - November 02, 2015

    TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
    BOARD OF PHARMACY
    Chapter 20
    Final Regulation

    REGISTRAR'S NOTICE: The Board of Pharmacy is claiming an exemption from Article 2 of the Administrative Process Act in accordance with § 2.2-4006 A 13 of the Code of Virginia, which exempts amendments to regulations of the board to schedule a substance in Schedule I or II pursuant to § 54.1-3443 D of the Code of Virginia. The board will receive, consider, and respond to petitions by any interested person at any time with respect to reconsideration or revision.

    Title of Regulation: 18VAC110-20. Regulations Governing the Practice of Pharmacy (amending 18VAC110-20-322).

    Statutory Authority: §§ 54.1-2400 and 54.1-3443 of the Code of Virginia.

    Effective Date: December 2, 2015.

    Agency Contact: Caroline Juran, RPh, Executive Director, Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463, telephone (804) 367-4416, FAX (804) 527-4472, or email caroline.juran@dhp.virginia.gov.

    Summary:

    The amendments place six compounds into Schedule I of the Drug Control Act. The added compounds will remain in effect for 18 months or until the compounds are placed in Schedule I by action of the General Assembly.

    18VAC110-20-322. Placement of chemicals in Schedule I.

    A. Pursuant to § 54.1-3443 D of the Code of Virginia, the Board of Pharmacy places the following substances in Schedule I of the Drug Control Act:

    1. Cannabimimetic agents:

    a. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other names: ADB-CHMINACA, MAB-CHMINACA);

    b. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other name: 5-fluoro-AMB);

    c. 1-naphthalenyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (other name: NM-2201); and

    d. 1-(4-fluorobenzyl)-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: FUB-144).

    2. Substituted cathinones:

    a. 4-bromomethcathinone (other name: 4-BMC); and

    b. 4-chloromethcathinone (other name: 4-CMC).

    B. The placement of drugs in this subsection shall remain in effect until February 11, 2017, unless enacted into law in the Drug Control Act.

    B. Pursuant to subsection D of § 54.1-3443 of the Code of Virginia, the Board of Pharmacy places the following in Schedule I of the Drug Control Act:

    1. Acetyl fentanyl (other name: desmethyl fentanyl).

    2. Etizolam.

    3. 4-Iodo-2, 5-dimethoxy-N-[(2-hydroxyphenyl) methyl]-benzeneethanamine (other name: 25I-NBOH).

    4. Cannabimimetic agent:

    1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl) indole (MAM-2201).

    5. Substituted cathinones:

    a. Alpha-Pyrrolidinohexiophenone (other name: alpha-PHP); and

    b. Alpha-Pyrrolidinoheptiophenone (other name: PV8).

    The placement of drugs listed in this subsection shall remain in effect until June 1, 2017, unless enacted into law in the Drug Control Act.

    VA.R. Doc. No. R16-4527; Filed October 13, 2015, 12:22 p.m.

Document Information

Rules:
18VAC110-20-322